Frontage Holdings Corporation (HKG:1521)
Hong Kong · Delayed Price · Currency is HKD 2.095
-0.030 (-1.41%)
Nov 11, 2026, 4:08 PM HKT
Frontage Holdings Market Cap
Frontage Holdings has a market cap or net worth of 4.26 billion as of November 10, 2026. It is the 13,862nd most valuable company in the world and the 640th biggest in Hong Kong. Its market cap has increased by 89.33% in one year.
Market Cap
4.26B
Enterprise Value
5.09B
Revenue
2.18B
Global Rank
Country Rank
#640 Hong Kong
PE Ratio
51.36
ChartMarket Cap Chart
Since May 30, 2019, Frontage Holdings's market cap has decreased from 6.73B to 4.26B, a decrease of -36.64%. That is a compound annual growth rate of -5.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 3.03B | 49.47% |
| Dec 31, 2025 | 2.03B | -43.71% |
| Dec 31, 2024 | 3.60B | -23.57% |
| Dec 29, 2023 | 4.71B | -20.20% |
| Dec 30, 2022 | 5.91B | -27.11% |
| Dec 31, 2021 | 8.10B | -6.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Mirxes Holding Company | 3.66B |
| Hanx Biopharmaceuticals (Wuhan) | 3.47B |
| TransThera Sciences (Nanjing) | 3.37B |
| Qyuns Therapeutics | 3.27B |
| Beijing Luzhu Biotechnology | 3.05B |
| Shanghai Bao Pharmaceuticals | 2.97B |
| Laekna | 2.81B |
| Medtide | 2.80B |